Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2022
2022 World Conference on Lung Cancer
As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2015
-
+
WS02 - IASLC CT Screening Symposium: Forefront Advances in Lung Cancer Screening (Ticketed Session) (In-person Access Only)
- Type: Workshop
- Track: N/A
- Presentations: 25
- Moderators:Chunxue Bai
- Coordinates: 8/05/2022, 09:00 - 16:00, Strauss 3
-
+
WS02.02 - Session Introduction
09:02 - 09:04 | Author(s): David Baldwin
- Abstract
Loading... -
+
WS02.08 - Session 1 Welcome
09:13 - 09:15 | Author(s): Stephen Lam
- Abstract
Loading... -
+
WS02.09 - Key Elements for Successful Implementation of a National Screening Program - The Taiwan Experience
09:15 - 09:25 | Author(s): Pan Chyr Yang
- Abstract
Loading... -
+
WS02.10 - LungPlan (Financial Modeling to Secure Resources for Lung Screening and Nodule Management Program)
09:25 - 09:35 | Author(s): Ella A Kazerooni
- Abstract
Loading... -
+
WS02.11 - LungPlan (Financial Modeling to Secure Resources for Lung Screening and Nodule Management Program)
09:35 - 09:45 | Author(s): Robert Smith
- Abstract
Loading... -
+
WS02.12 - Optimal Smoking Cessation Strategy
09:45 - 09:55 | Author(s): Matthew Peters
- Abstract
Loading... -
+
WS02.13 - Panel Discussion & Live Q&A
09:55 - 10:25
- Abstract
Loading... -
+
WS02.15 - Session 2 Welcome
10:40 - 10:43 | Author(s): David Baldwin
- Abstract
Loading... -
+
WS02.17 - Training, Assessment and Standardized Cad-Based Reporting - The British Columbia Lung Screening Program
10:45 - 10:55 | Author(s): Stephen Lam
- Abstract
Loading... -
+
WS02.18 - IASLC Education Resource Initiative
10:55 - 11:05 | Author(s): Natthaya Triphuridet
- Abstract
Loading... -
+
WS02.19 - Quality Assurance of Radiology Reporting: PERFECTS
11:05 - 11:15 | Author(s): Yan Chen
- Abstract
Loading... -
+
WS02.20 - CAD/AI in Screening Interpretation: From Detection through Management
11:15 - 11:25 | Author(s): Matthijs Oudkerk
- Abstract
Loading... -
+
WS02.21 - Panel Discussion & Live Q&A
11:25 - 11:55
- Abstract
Loading... -
+
WS02.24 - Welcome Back/Q&A from Morning Sessions
13:03 - 13:10 | Author(s): Harry J de Koning
- Abstract
Loading... -
+
WS02.25 - Assessing Lung Cancer Risk from a Single Chest CT
13:10 - 13:20 | Author(s): Marjolein Heuvelmans
- Abstract
Loading... -
+
WS02.26 - Personalized Risk Assessment Using Blood and Imaging Biomarkers
13:20 - 13:30 | Author(s): Hilary A Robbins
- Abstract
Loading... -
+
WS02.27 - Deep Learning Approach to Optimize the Lung Cancer Screening Interval
13:30 - 13:40 | Author(s): Ping Hu
- Abstract
Loading... -
+
WS02.28 - Future Directions Using AI Technologies for Early Lung Cancer Detection
13:40 - 13:50 | Author(s): Georg Langs
- Abstract
Loading... -
+
WS02.29 - Panel Discussion & Live Q&A
13:50 - 14:20
- Abstract
Loading... -
+
WS02.31 - Session 4 Welcome
14:30 - 14:33 | Author(s): Ella A Kazerooni
- Abstract
Loading... -
+
WS02.34 - Incidental Lung Nodules - An Opportunity to Advance Early Lung Cancer Detection
14:45 - 14:55 | Author(s): Raymond U Osarogiagbon
- Abstract
Loading... -
+
WS02.35 - Benchmarks for Diagnostic Workup of Early Lung Cancer
14:55 - 15:05 | Author(s): Annette Maree McWilliams
- Abstract
Loading... -
+
WS02.36 - Additional Findings in Lung Cancer Screening
15:05 - 15:15 | Author(s): David Baldwin
- Abstract
Loading... -
+
WS02.37 - Panel Discussion & Live Q&A
15:15 - 15:40
- Abstract
Loading... -
+
WS02.38 - Workshop Summary/Conclusion
15:40 - 15:50 | Author(s): John K Field
- Abstract
Loading...
-
+
WS08 - Joint IASLC-CSCO-CAALC Session: Liquid Biopsy in Oncogene Driven NSCLC (On-demand)
- Type: Workshop
- Track: N/A
- Presentations: 17
- Moderators:Yi-Long Wu
- Coordinates: 8/06/2022, 21:00 - 23:59, On-Demand
-
+
WS08.05 - Minimal Residual Disease (MRD) Negative: Potential for Cure in Resected Oncogene Driven NSCLC? Chinese Perspective
21:10 - 21:30 | Author(s): Jia-Tao Zhang
- Abstract
Loading... -
+
WS08.06 - Could MRD Change Our Clinical Practice? North American Perspective
21:30 - 21:50 | Author(s): Aadel Chaudhuri
- Abstract
Loading... -
+
WS08.07 - How to Use Liquid Biopsy to Monitor Treatment Efficacy for Advanced Driven NSCLC
21:50 - 22:10 | Author(s): Jie Hu
- Abstract
Loading... -
+
WS08.09 - Sintilimab versus Pembrolizumab as Monotherapy or in Combination with Chemotherapy for Treatment Naïve Metastatic Non-small Cell Lung Cancer
22:30 - 22:40 | Author(s): Si-Yang Maggie Liu
- Abstract
Loading... -
+
WS08.10 - Toripalimab in Combination with CIK Cells in Patients with Advanced NSCLC: An Exploratory Study
22:40 - 22:50 | Author(s): Baohui Han
- Abstract
Loading... -
+
WS08.13 - Activity of aPD1-MSLN-CART Cells Against Metastatic Lung Cancer in a Phase 1 Trial
23:20 - 23:21 | Author(s): Lingjuan Chen
- Abstract
Loading... -
+
WS08.14 - Final Analyses of ALTER-L018: A Randomized Phase II Trial of Anlotinib Plus Docetaxel vs Docetaxel as 2nd-line Therapy for EGFR-Negative NSCLC
23:21 - 23:22 | Author(s): Lin Wu
- Abstract
Loading... -
+
WS08.15 - Safety and Efficacy of Sitravatinib + Tislelizumab in Patients with PD-L1+, Locally Advanced/Metastatic, Squamous NSCLC
23:22 - 23:23 | Author(s): Jun Zhao
- Abstract
Loading... -
+
WS08.16 - The Increase of Blood Intratumor Heterogeneity is Associated with Unfavorable Outcomes of ICIs Plus Chemotherapy in NSCLC
23:23 - 23:24 | Author(s): Juan Zhou
- Abstract
Loading... -
+
WS08.17 - Utilization of Tumor Mutational Profiling to Identify the Immunotherapy Response in Non-small Cell Lung Cancer
23:24 - 23:25 | Author(s): Peng Song
- Abstract
Loading... -
+
WS08.18 - Discussant for Poster 1 - 5
23:25 - 23:40 | Author(s): Xiaorong Dong
- Abstract
Loading... -
+
WS08.24 - Discussant for Poster 6 - 10
23:35 - 23:50 | Author(s): Ming Fang Zhao
- Abstract
Loading... -
+
WS08.19 - Phase Il Trial of Neoadjuvant Tislelizumab with Chemotherapy for Resectable Stage IIB-III Non-small Cell Lung Cancer
23:40 - 23:41 | Author(s): Yao-Bin Lin
- Abstract
Loading... -
+
WS08.20 - Comprehensive Analysis of a Dendritic Cell Marker Genes Signature to Predict Prognosis and Immunotherapy Response in Lung Adenocarcinoma
23:41 - 23:42 | Author(s): Yuan Li
- Abstract
Loading... -
+
WS08.21 - Immune Evolution of Metastases & Underlying Molecular Mechanisms in Non-small Cell Lung Cancer
23:42 - 23:43 | Author(s): Wen-Fang Tang
- Abstract
Loading... -
+
WS08.22 - Neoadjuvant Toripalimab Combination in Patients with Stage IIB-IIIB NSCLC: A Single-arm, Phase 2 Trial (Renaissance Study)
23:43 - 23:44 | Author(s): Shi Yan
- Abstract
Loading... -
+
WS08.23 - Transcriptomic Heterogeneity in Non-Small Cell Lung Cancer with Four Structure-Based EGFR-Mutation Subgroups
23:44 - 23:45 | Author(s): LinPing Gu
- Abstract
Loading...
